Health Technology Assessment for the Prevention of Peri-Operative Hypothermia: Evaluation of the Correct Use of Forced-Air Warming Systems in an Italian Hospital

Int J Environ Res Public Health. 2022 Dec 22;20(1):133. doi: 10.3390/ijerph20010133.

Abstract

This study investigates the implications of using a system for the maintenance of normothermia in the treatment of patients undergoing surgery, determining whether the FAW (Forced-Air Warming) systems are more effective and efficient than the non-application of appropriate protocols (No Technology). We conducted Health Technology Assessment (HTA) analysis, using both real-world data and the data derived from literature, assuming the point of view of a medium-large hospital. The literature demonstrated that Inadvertent Perioperative Hypothermia (IPH) determines adverse events, such as surgical site infection (FAW: 3% vs. No Technology: 12%), cardiac events (FAW: 3.5% vs. No Technology: 7.6%) or the need for blood transfusions (FAW: 6.2% vs. No Technology: 7.4%). The correct use of FAW allows a medium saving of 16% per patient to be achieved, compared to the non-use of devices. The Cost Effectiveness Value (CEV) is lower in the hypothesis of FAW: it enables a higher efficacy level with a contextual optimization of patients' path costs. The social cost is reduced by around 30% and the overall hospital days are reduced by between 15% and 26%. The qualitative analyses confirmed the results. In conclusion, the evidence-based information underlines the advantages of the proper use of FAW systems in the prevention of accidental peri-operative hypothermia for patients undergoing surgery.

Keywords: active warming; forced-air warming; hypothermia; inadverted perioperative hypothermia; normothermia; surgical patient; temperature management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Temperature
  • Cost-Effectiveness Analysis
  • Humans
  • Hypothermia* / prevention & control
  • Rewarming / methods
  • Surgical Wound Infection / prevention & control
  • Technology Assessment, Biomedical

Grants and funding

This research received no external funding. The APC was funded by 3M Italia.